CLARA | Jotup

CLARA Analytics and Origami Risk Partner to Accelerate AI Adoption for Risk Managers and Claim Handlers

Retrieved on:

星期二, 四月 30, 2024

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced the company is expanding its relationship with Origami Risk (“Origami”), the industry-leading risk, safety and insurance software as a service (SaaS) technology firm.

Key Points:

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced the company is expanding its relationship with Origami Risk (“Origami”), the industry-leading risk, safety and insurance software as a service (SaaS) technology firm.
The partnership between CLARA and Origami will enable risk managers to fast-track their adoption of AI, giving them immediate access to secure, SOC2 compliant, and HIPAA compliant technology.
Seamless bi-directional integration with Origami provides a wealth of data to CLARA’s AI platform, which delivers key insights to risk managers and adjusters, case summaries, and other relevant information.
“Risk management and claims professionals understand that they need to embrace AI,” said Earne Bentley, President, Risk Solutions at Origami, “but they’re understandably concerned about security and compliance.

Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial

Retrieved on:

星期二, 四月 30, 2024

Health, Stem Cells, Clinical Trials, Pharmaceutical, Optical, Biotechnology, CLARA, Safety, MD, Patient, Eye, Physician, Charles River Laboratories, MBA, Clinical trial, Pharmaceutical industry

“Aurion Biotech is delighted that both enrollment and dosing in our Phase 1/2 trial are now complete, and that it happened more rapidly than we expected,” said Michael Goldstein, MD, MBA, President and Chief Medical Officer of Aurion Biotech.

Key Points:

“Aurion Biotech is delighted that both enrollment and dosing in our Phase 1/2 trial are now complete, and that it happened more rapidly than we expected,” said Michael Goldstein, MD, MBA, President and Chief Medical Officer of Aurion Biotech.
The CLARA Phase 1 / 2 clinical trial is a prospective, multi-center, randomized, double masked, parallel-arm cell dose-ranging clinical trial in subjects with corneal edema secondary to corneal endothelial dysfunction.
The CLARA trial is designed to assess the safety, tolerability, and efficacy of AURN001 for the treatment of corneal edema secondary to corneal endothelial dysfunction.
Drug product for the CLARA trial was supplied by Aurion’s CDMO partner, Charles River Laboratories, from their production site in Memphis, TN.

Top 10 Personal Auto Carrier Turns to AI to Transform Claims Management

Retrieved on:

星期三, 四月 17, 2024

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced it has been selected by one of the world’s largest personal auto insurance companies as the foundation for their AI-enabled claims management initiatives.

Key Points:

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced it has been selected by one of the world’s largest personal auto insurance companies as the foundation for their AI-enabled claims management initiatives.
CLARA helps carriers to make sense of voluminous information, streamline claims management, improve medical outcomes, and reduce administrative burdens for adjusters.
CLARA’s AI technology ingests incoming medical records and demand letters, identifies key information including problematic legal language, flags key deadlines and action items, and updates claims managers as new information emerges.
CLARA’s AI technology also delivers succinct case summaries that help adjusters to work efficiently and effectively, focusing their attention on the claims with the highest potential impact.

CLARA Analytics Achieves Record Revenue Growth, Accelerates Innovation

Retrieved on:

星期三, 三月 6, 2024

The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.

Key Points:

The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.
“Investors, industry leaders, and analysts are responding extremely positively to CLARA’s rapid growth and customer success,” said CLARA Analytics CEO Heather H. Wilson .
Last month, CLARA announced yet another infusion of capital from Nationwide Ventures , which invests in companies that are shaping the future of insurance and financial services.
CLARA’s growth is fueled by its track record of delivering strong ROI for its customers, along with its reputation for industry-leading innovation and customer service.

CLARA Analytics Secures Funding From Nationwide

Retrieved on:

星期三, 二月 21, 2024

Professional Services, Data Analytics, Technology, Insurance, Software, Finance, Artificial Intelligence, Natural language processing, AI, Nationwide, E&S, Growth, Commercial, Human, CLARA, Venture round, NLP, Partnership

CLARA Analytics and Nationwide are deepening their current partnership.

Key Points:

CLARA Analytics and Nationwide are deepening their current partnership.
CLARA has received an investment from Nationwide Ventures , the investment arm of the insurance and financial services company.
“The Nationwide investment is a huge vote of confidence from a leading voice in the industry,” said Heather H. Wilson , CEO of CLARA Analytics.
“ Since partnering together in 2022 , Nationwide has seen the very substantial benefits that this technology can offer,” said George Williams, Chief Operating Officer of Commercial, E&S and Specialty at Nationwide.

MEMIC Selects CLARA Analytics to Read and Summarize Medical Records With AI

Retrieved on:

星期三, 一月 17, 2024

CLARA Optics uses predictive AI, generative AI (GenAI), and large language models (LLMs) to automate medical records transcription, extract meaningful details, and deliver actionable insights to claims management personnel.

Key Points:

CLARA Optics uses predictive AI, generative AI (GenAI), and large language models (LLMs) to automate medical records transcription, extract meaningful details, and deliver actionable insights to claims management personnel.
“We anticipate that CLARA Optics will create greater efficiencies across our claim operation,” said Matt Harmon, senior vice president of claims at MEMIC.
CLARA’s AI platform assists claims managers by offering up-to-the-minute case summaries derived from both structured and unstructured contributory data.
“MEMIC is widely recognized as a leader in the workers’ compensation space,” said Heather H. Wilson , CEO of CLARA Analytics.

CLARA Analytics Launches Industry’s First Holistic Casualty Claims Intelligence Platform, CLARAty.ai, to Reshape Claims Management

Retrieved on:

星期二, 十月 31, 2023

Professional Services, Technology, Insurance, Artificial Intelligence, Software, Intelligence, Booth, History, Mandalay Bay, Gamma globulin, ITC, Artificial intelligence, Structural load, Ecosystem, CLARA, AI, MGA, 3D printing, Sales

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today unveiled its CLARAty.ai platform, which advances the insurance claims process and assists claims professionals with their day-to-day work.

Key Points:

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today unveiled its CLARAty.ai platform, which advances the insurance claims process and assists claims professionals with their day-to-day work.
With the launch of CLARAty.ai, CLARA redefines what should be considered as part of the core ecosystem.
Rather than rely on separate claims solutions for different casualty lines, CLARA supports workers’ comp, auto liability, and general liability claims, with more to come in the near future.
By adding an intelligence layer to core admin systems, everything claims professionals need is accessible,” said CLARA Analytics CEO Heather H. Wilson .

CLARA Analytics Raises $24M in Series C Funding, Accelerating AI Adoption for Insurance Claims

Retrieved on:

星期四, 九月 7, 2023

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced its $24 million Series C funding, bringing its total funding to $60 million.

Key Points:

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced its $24 million Series C funding, bringing its total funding to $60 million.
“Insurers are facing increased pressure to manage losses and expenses, and they have awakened to the value that AI can generate in claims management.
CLARA intends to use the investment to further enhance its platform’s leading AI capabilities, including generative AI, predictive modeling, and natural language processing capabilities.
CLARA’s platform of AI-based software includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance .

CLARA Analytics and ClaimDeck Combat Growing Litigation Rates and Rising Social Inflation

Retrieved on:

星期三, 八月 23, 2023

Legal, Technology, Insurance, Professional Services, Health Insurance, Software, Health, Data Management, Artificial Intelligence, CLARA, Artificial intelligence, Software as a service, AI, MGA, Partnership, Risk management

CLARA Analytics (“CLARA”), the leading provider of artificial intelligence (AI) technology for commercial insurance claims optimization, and ClaimDeck , the industry’s leading SaaS-based, process-driven litigation management platform, today announced they have formed a strategic partnership to help carriers manage their litigation rates and drive better legal outcomes.

Key Points:

CLARA Analytics (“CLARA”), the leading provider of artificial intelligence (AI) technology for commercial insurance claims optimization, and ClaimDeck , the industry’s leading SaaS-based, process-driven litigation management platform, today announced they have formed a strategic partnership to help carriers manage their litigation rates and drive better legal outcomes.
Both CLARA and ClaimDeck insurance claims solutions are innovative technology platforms that use claims data to optimize the litigated claims outcome and mitigate rising litigation costs.
ClaimDeck provides a platform for insurers and defense attorneys to collaborate and a workflow engine to ensure best practices are followed.
“The seamless integration of our tools with ClaimDeck will facilitate improved decision-making, lower legal expenses, and measurable improvements in casualty claims litigation outcomes.”

CLARA Analytics’ AI Platform Extracts Deep Context From Plaintiff Legal Demands

Retrieved on:

星期四, 八月 17, 2023

CLARA Optics automates the transcription of medical records and legal correspondence, then highlights important details about each claim using industry-focused AI technology.

Key Points:

CLARA Optics automates the transcription of medical records and legal correspondence, then highlights important details about each claim using industry-focused AI technology.
View the full release here: https://www.businesswire.com/news/home/20230817434685/en/
CLARA Optics automatically extracts, analyzes and summarizes legal demands.
“Unlike our competitors, CLARA incorporates deep property and casualty insurance domain-specific context,” said Mubbin Rabbani , Vice President of Product at the company.
Rather than simply adapting general-purpose AI tools to claims management, CLARA has built its platform from the ground up with insurance claims in mind.